AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Change in Account Payables of $6.0 million for Q1 2026, up 16447.22% year-over-year from N/an in Q1 2025, and up 16447.22% quarter-over-quarter from $36000.0 in Q1 2025.

Analysis

AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026) Analysis & Trends

AtaiBeckley has reported Change in Account Payables for 6 years, with the latest figure at $1.8 million in Q3 2025.

  • Quarterly Change in Account Payables rose 71.9% year-over-year to $1.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $442000.0 (up 163.41% YoY) and the FY2024 annual result came in at -$1.9 million, down 187.56% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $6.0 million, up from $36000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $6.0 million in Q1 2026, with the low at $36000.0 in Q1 2025.
  • A 5-year average of $110894.7 and a median of -$22000.0 in 2024 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2021 and 2025: Change in Account Payables plunged 1138.72% in 2021, then soared 3631.82% in 2025.
  • Over 5 years, Change in Account Payables stood at $4.0 million in 2021, then tumbled by 115.06% to -$598000.0 in 2022, then sank by 60.2% to -$958000.0 in 2023, then slumped by 122.65% to -$2.1 million in 2024, then surged by 182.61% to $1.8 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $1.8 million, $777000.0, and $36000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AtaiBeckley 1.61 Bn 1.61 Bn - 1.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 788,000.00
Mar 31, 2026 5.96 Mn
Sep 30, 2025 1.76 Mn
Jun 30, 2025 777,000.00
Jun 30, 2025 777,000.00
Mar 31, 2025 36,000.00
Mar 31, 2025 36,000.00
Dec 31, 2024 -2.13 Mn
Sep 30, 2024 1.03 Mn
Jun 30, 2024 -22,000.00
Mar 31, 2024 -742,000.00
Dec 31, 2023 -958,000.00
Sep 30, 2023 1.69 Mn
Jun 30, 2023 -1.07 Mn
Mar 31, 2023 2.48 Mn
Dec 31, 2022 -598,000.00
Sep 30, 2022 155,000.00
Jun 30, 2022 -705,000.00
Mar 31, 2022 -1.89 Mn
Dec 31, 2021 3.97 Mn